PowerShares DWA Healthcare Momentum Portfolio PTH 深 沪
等待开盘 07-17 09:30:00 美东时间
38.2393
+0.389
+1.03%
华盛通- 最 高38.2393
- 今 开38.09
- 成交量 3379股
- 最 低 37.7801
- 昨 收 37.85
- 总市值 1.02亿
- 52周最高 48.63
- 市盈率 静 --
- 换手率 0.13%
- 52周最低 33.5611
- 委 比 -14.29%
- 总股本 266.00万
- 历史最高 64.6295
- 量 比 0.14
- 振 幅 1.21%
- 历史最低 6.9445
- 每 手 1
- 风险率 3.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ascendis Pharma To Present New Data From Week 156 Of Phase 3 PaTHway Trial Demonstrating Safety And Efficacy Of Long-Term Treatment With TransCon PTH In Adults With Hypoparathyroidism, At ENDO 2025
Ascendis Pharma A/S (NASDAQ:ASND) today announced two oral presentations at ENDO 2025, the annual meeting of the Endocrine Society being held July 12-15, 2025, in San Francisco. Dr. Aliya Khan will present new data from
07-08 04:03
Why Is Channel Therapeutics Stock Surging On Friday?
Channel Therapeutics shares rise after announcing 10-for-1 reverse stock split and upcoming rebrand.
06-27 23:55
The Analyst Verdict: Septerna In The Eyes Of 4 Experts
4 analysts have shared their evaluations of Septerna (NASDAQ:SEPN) during the r...
06-23 20:02
Hims & Hers Health Sees Major Growth Opportunity In Booming Weight Loss Market, Says Analyst
Needham analyst initiates coverage on Hims & Hers Health, Inc. with a Buy rating and $24 price target. Anticipates positive impact from GLP-1 market entry and strong growth potential.
2024-08-23 02:26
